Serotonin-noradrenaline-dopamine reuptake inhibitor

Serotonin-norepinephrine-dopamine-reuptake-inhibitors (SNDRI) are a class of dopamine. These three biogenic monoamines are associated with depression and increasing the availability in the brain is used to treat the disease.